Skip to main content
. 2015 Apr 19;32(4):356–369. doi: 10.1007/s12325-015-0205-5

Fig. 2.

Fig. 2

Confocal images of a patient treated with latanoprost. a Sub-basal plexus at baseline. b Anterior stroma at baseline; no keratocyte activation is present. c Sub-basal plexus at month 12: disruption of normal nerve structure is shown: branching and beading are present, and nerve is tortuous; density is overall conserved. d Anterior stroma at month 12 showing keratocyte activation